PPD Box containing Blood-taking Items for Phase 3 Novavax 2019nCoV-302 Vaccine Trial

PART OF:
Kit for phase 3 Novavax 2019nCoV-302 vaccine trial at Stockport NHS Foundation Trust
Made:
2020

PPD box containing blood-taking items from kit for phase 3 Novavax 2019nCoV-302 vaccine trial at Stockport NHS Foundation Trust.

Launched in September 2020, the phase 3 trial of Novavax’s vaccine was the largest ever double blind placebo controlled trial to be undertaken in the United Kingdom. This meant that the researchers or participants did not know what injection people received. Half of the participants were given the active vaccine and the other half, an inactive solution.15,000 people were involved from 35 research sites. The highest recruiting region was Greater Manchester with 1240 volunteers from Stockport NHS Foundation Trust and the Northern Care Alliance NHS Group. This kit was used with volunteers to monitor them during the trial and represents the crucial role volunteers play in the process.

Phase 3 trial results showed an overall 89.7% efficacy rate including against alpha and beta variants of the virus. Earlier clinical trials were carried out in Australia, United States and South Africa. All volunteers who received placebo solution are to be offered the active vaccine.

Details

Category:
Public Health & Hygiene
Object Number:
2022-1441/4
Materials:
plastic (unidentified), cardboard and paper (fibre product)
type:
test kit (medical)
credit:
Novavax, Inc

Parts

PPD Box for Phase 3 Novavax 2019nCoV-302 Vaccine Trial

PPD Box for Phase 3 Novavax 2019nCoV-302 Vaccine Trial

Materials:
cardboard
Object Number:
2022-1441/4/1
type:
box - container
Box for Digital Thermometer for Phase 3 Novavax 2019nCoV-302 Vaccine Trial

Box for Digital Thermometer for Phase 3 Novavax 2019nCoV-302 Vaccine Trial

Materials:
cardboard
Object Number:
2022-1441/4/2/2
type:
box - container
Part of:
2022-1441/4/2
Blank Study Identification Card for Phase 3 Novavax 2019nCoV-302 Vaccine Trial

Blank Study Identification Card for Phase 3 Novavax 2019nCoV-302 Vaccine Trial

Materials:
paper (fibre product)
Object Number:
2022-1441/4/3
type:
identity card
“Do Not Mix Kits” Warning Notice for phase 3 Novavax 2019nCoV-302 vaccine trial

“Do Not Mix Kits” Warning Notice for phase 3 Novavax 2019nCoV-302 vaccine trial

Materials:
paper (fibre product)
Object Number:
2022-1441/4/4
type:
notice
PPD Sticker for Phase 3 Novavax 2019nCoV-302 Vaccine Trial

PPD Sticker for Phase 3 Novavax 2019nCoV-302 Vaccine Trial

Materials:
plastic (unidentified)
Object Number:
2022-1441/4/5
type:
sticker
Pipette for Blood Collection Kit for Phase 3 Novavax 2019nCoV-302 Vaccine Trial

Pipette for Blood Collection Kit for Phase 3 Novavax 2019nCoV-302 Vaccine Trial

Materials:
plastic (unidentified)
Object Number:
2022-1441/4/6/5
type:
pipette
Part of:
2022-1441/4/6
PPD Requisition Form for Phase 3 Novavax 2019nCoV-302 Vaccine Trial

PPD Requisition Form for Phase 3 Novavax 2019nCoV-302 Vaccine Trial

Materials:
paper (fibre product)
Object Number:
2022-1441/4/7
type:
form - document